CFAI
C.F.A.I.
Government Data Intelligence Services

Ohm Laboratories, Inc.

Company NJ
Found in 3 federal databases · 27 total records
fda 23 records
FDA Drug Recall: Leader Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets pe 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Sunmark loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10- 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Safeway Care Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: TopCare LORATIDINE ORALLY DISINTEGRATING TABLETS, , USP, 10 mg, packaged in a) C 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Health Mart Pharmacy loratadine orally disintegrating tablets, USP, 10 mg, 10-co 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Ohm Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets, Dist 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Discount Drug Mart Food Fair, Original Prescription Strength, Loratadine Orally 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: HEB Loratadine Orally Disintegrating Tablets, USP, 10 mg, 10-count tablets per b 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Meijer Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets pe 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Wal-itin Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Fred's Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-counts tablets p 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: CareOne Original Prescription Strength, Allergy Relief, Loratadine Orally Disint 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: QC Quality Choice Loratadine Orally Disintegrating Tablets, USP 10 mg, 10-count 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Health Best Choice Care, Loratadine Orally Disintegrating Tablets, USP, 10 mg, 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Major loratadine orally disintegrating tablets, USP, 10 mg, 10-count tablets per 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Good Neighbor Pharmacy Loratadine Orally Disintegrating Tablets, USP, 10 mg, pac 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: CVS Pharmacy, Original Prescription Strength, LORATADINE ORALLY DISINTEGRATING T 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Rite Aid Pharmacy loratadine orally disintegrating tablets USP, 10 mg, packaged 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Equaline Original Prescription Strength, loratadine orally disintegrating tablet 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Premier Value Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tab 2015-10-21
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Loratadine Orally Disintegrating Tablets USP, 10 mg, Antihistamine, Allergy Reli 2015-06-24
Class III — Superpotent Drug: Out Of Specification (OOS) result for Assay.
View Source
FDA Drug Recall: Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrin 2014-04-30
Class II — Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg.
View Source
fda_adverse 3 records
FDA AE Manufacturer: OHM LABORATORIES INC.
Drug adverse event reporter — Product: OMEPRAZOLE
View Source
FDA AE Manufacturer: Ohm Laboratories, Inc.
Drug adverse event reporter — Product: GUAIFENESIN
View Source
FDA AE Manufacturer: OHM LABORATORIES INC
Drug adverse event reporter — Product: LEVONORGESTREL
View Source
ny_corps 1 records
NY Corp: OHM LABORATORIES INC. 2005-02-07
FOREIGN BUSINESS CORPORATION | County: Fulton | Jurisdiction: New Jersey
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.
Search Sources About The Signal Screening Terms Privacy
© 2026 CFAISOLUTIONS LLC · cfai.app · CourtPulse
C.F.A.I. aggregates publicly available federal records for informational purposes only. Nothing on this site constitutes legal, financial, or professional advice. No claims are made regarding the accuracy or completeness of any data presented.